Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06981013 · ClinicalTrials.gov registry record · NA

Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of St. Augustine for Health Sciences.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06981013: Recruiting NA study of Multiple Sclerosis, sponsored by University of St. Augustine for Health Sciences.

NCT06981013 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by University of St. Augustine for Health Sciences. The registered enrollment target is 40 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06981013, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by University of St. Augustine for Health Sciences.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Rationale: The Balance-Based Torso-Weighting (BBTW) is a patented evaluation system that uses strategic placement of small or lightweight weights on the trunk to improve balance and stability. BBTW has been found to improve the upright mobility of people with multiple sclerosis, however the mechanism underlying the improvement of balance and gait is still unknown.1-2 Purpose: The purpose of this study is to investigate the immediate effects of BBTW on muscle activation of tibialis anterior and gastrocsoleus and sway using electromyography and force plates during balance tests in people with MS and healthy controls?

Primary Outcome

Noraxon EMG will be used to measure muscle activation

Conditions Studied

Interventions

  • OTHER balance based torso weighting

Study Locations (1)

Florida

  • University of St. Augustine for Health Sciences - Saint Augustine

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-01
Est. Completion 2026-12
Phase NA

What NCT06981013 shows while recruiting

NCT06981013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which balance based torso weighting is the first listed.

NCT06981013 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06981013 about?

NCT06981013 is a clinical study titled "Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis". Rationale: The Balance-Based Torso-Weighting (BBTW) is a patented evaluation system that uses strategic placement of small or lightweight weights on the trunk to improve balance and stability. BBTW has been found to improve the upright mobility of people with multiple sclerosis, however the mechanis...

What is the current status of trial NCT06981013?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-01. Estimated completion is 2026-12.

What conditions does trial NCT06981013 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06981013?

The interventions under investigation include: balance based torso weighting (OTHER).

Who is sponsoring clinical trial NCT06981013?

This trial is sponsored by University of St. Augustine for Health Sciences, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06981013 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06981013's enrollment target sits among peer trials

40 197th of 315 higher than 108 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06981013, the US trial registry maintained by the National Library of Medicine. NCT06981013 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.